BGS vs JAZZ · rev $792.2M vs P/E 1988, rev $2.28B
B&G Foods Inc (BGS) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
B&G Foods Inc (BGS) is a packaged foods company listed on NYSE.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported BGS revenue for 2026-07-04 was $792.2M. Net income was -$36.5M. Revenue was up 93.7% from 2026-04-04 to 2026-07-04. BGS currently screens at market cap $316.6M.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
BGS currently screens at market cap $316.6M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the BGS and JAZZ stock pages for the full models.
Not investment advice.